Population aging is a global phenomenon, and while not as critical as finding cures for cancer or rare diseases, anti-aging therapies – a branch of regenerative medicine – have consistently intrigued researchers, investors, and biotech entrepreneurs for the last decade.

Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…